The Raleigh (North Carolina) News & Observer is reporting that Voyager Pharmaceutical Corporation has put its trial of Memryte (leuprolide acetate) on hold because of “clinical and financial issues.” The trial was based on the hypothesis that midlife changes in reproductive hormones (in this case luteinizing hormone) are an underlying cause of Alzheimer’s. According to the article, the company hopes to find more funding and restart trials in eighteen months.
Looks like we’ll have to rely on other trials and studies to find out more about the relationship between reproductive hormones and Alzheimer’s…
I wonder what the clinical issues are but that they're stopping due to funding issues is VERY sad.
Posted by: Karma | October 26, 2006 at 02:09 PM